Hernández-Allés S, Conejo M d, Pascual A, Tomás J M, Benedí V J, Martínez-Martínez L
Department of Biology, Area of Microbiology and IMEDEA-CSIC, University of the Balearic Islands, Spain.
J Antimicrob Chemother. 2000 Aug;46(2):273-7. doi: 10.1093/jac/46.2.273.
The activities of beta-lactams, chloramphenicol, tetracycline, fluoroquinolones and aminoglycosides against Klebsiella pneumoniae C3 (O1:K66, producing porins OmpK35 and OmpK36) and a set of isogenic mutants derived from it lacking the O antigen of lipopolysaccharide (LPS), capsular K antigen, or one or both porins were determined. MICs remained within one dilution step in mutants deficient in antigen O, in capsule or in one of the two porins. No increases in the MICs of aminoglycosides, fluoroquinolones, tetracycline and chloramphenicol were observed for strains deficient in the two porins, but the MICs of ampicillin, cephalothin, cefoxitin, cefotaxime and ceftazidime for this type of mutant increased four- to >256-fold. The highest MICs of beta-lactams were obtained in a porin-deficient mutant expressing increased beta-lactamase activity. It is concluded that isolated outer membrane alterations in K. pneumoniae are not decisive factors in increasing resistance to antimicrobial agents, but porin loss co-operates with beta-actamase production to increase resistance to beta-lactams.
测定了β-内酰胺类、氯霉素、四环素、氟喹诺酮类和氨基糖苷类对肺炎克雷伯菌C3(O1:K66,产生孔蛋白OmpK35和OmpK36)以及一组由其衍生的同基因突变体的活性,这些突变体缺乏脂多糖(LPS)的O抗原、荚膜K抗原或一种或两种孔蛋白。在缺乏O抗原、荚膜或两种孔蛋白之一的突变体中,最低抑菌浓度(MIC)保持在一个稀释步骤内。对于缺乏两种孔蛋白的菌株,未观察到氨基糖苷类、氟喹诺酮类、四环素和氯霉素的MIC增加,但此类突变体对氨苄西林、头孢噻吩、头孢西丁、头孢噻肟和头孢他啶的MIC增加了4倍至>256倍。在表达增加的β-内酰胺酶活性的孔蛋白缺陷突变体中获得了β-内酰胺类的最高MIC。得出的结论是,肺炎克雷伯菌中分离的外膜改变不是增加对抗菌剂耐药性的决定性因素,但孔蛋白缺失与β-内酰胺酶产生协同作用以增加对β-内酰胺类的耐药性。